Psychiatry Research
Volume 134, Issue 3 , Pages 251-258 , 30 April 2005

Effects of serotonin and serotonergic agonists and antagonists on the production of tumor necrosis factor α and interleukin-6

  • Marta Kubera

      Affiliations

    • Department of Experimental Neuroendocrinology, Institute of Pharmacology, Polish Academy of Sciences, Smętna 12, PL 31-343 Kraków, Poland
    • Corresponding Author InformationCorresponding author. Tel.: +48 12 637 40 22; fax: +48 12 637 45 00.
    • ,
  • Michael Maes

      Affiliations

    • Department of Psychiatry, University Hospital of Maastricht, the Netherlands
    • Clinical Research Center for Mental Health, Limburg, Belgium
    • Department of Psychiatry, Vanderbilt University, Nashville, TN, USA
    • ,
  • Gunter Kenis

      Affiliations

    • Department of Psychiatry, University Hospital of Maastricht, the Netherlands
    • ,
  • Yong-Ku Kim

      Affiliations

    • Department of Psychiatry, College of Medicine, Korea University, Seoul, South Korea
    • ,
  • Władysław Lasoń

      Affiliations

    • Department of Experimental Neuroendocrinology, Institute of Pharmacology, Polish Academy of Sciences, Smętna 12, PL 31-343 Kraków, Poland

Received 6 September 2003 ,Accepted 17 January 2004.

References 

  1. Ameisen J-C, Meade R, Askenase PW. A new interpretation of the involvement of serotonin in delayed-type hypersensitivity: serotonin-2 receptor antagonists inhibit contact sensitivity by an effect on T cells. Journal of Immunology. 1989;142:3171–3179
  2. Arzt E, Costas M, Finkielman S, Nahmod VE. Serotonin inhibition of tumor necrosis factor-alpha synthesis by human monocytes. Life Sciences. 1991;48:2557–2562
  3. Askenase PW, Herzog WR, Millet I, Paliwal V, Ramabhadran R, Rochester C, et al. Serotonin initiation of delayed-type hypersensitivity: mediation by a primitive Thy-1 antigen-specific clone or by specific monoclonal IgE antibody. Skin Pharmacology. 1991;4:25–42
  4. Aune TM, McGrath KM, Sarry T, Bombara MP, Kelley KA. Expression of 5HT1a receptors on activated human T cells. Journal of Immunology. 1993;151:1175–1183
  5. Aune MT, Golden HW, McGrath KM. Inhibitors of serotonin synthesis and antagonists of serotonin 1A receptors inhibit T lymphocyte function in vitro and cell-mediated immunity in vivo. Journal of Immunology. 1994;153:489–498
  6. Benedict CR, Mathew B, Rex KA, Cartwright J, Sordahl LA. Correlation of plasma serotonin changes with platelet aggregation in an in vivo dog model of spontaneous occlusive coronary thrombus formation. Circulation Research. 1986;58:58–67
  7. Bonhaus DW, Bach C, DeSouza A, Salazar FH, Matsuoka BD, Zuppan P, et al. The pharmacology and distribution of human 5-hydroxytryptamine2B (5-HT2B) receptor gene products: comparison with 5-HT2A and 5-HT2C receptors. British Journal of Pharmacology. 1995;115:622–628
  8. Bruunsgaard H, Pedersen AN, Schroll M, Skinhoj P, Pedersen BK. TNF-alfa, leptin, and lymphocyte function in human aging. Life Sciences. 2000;67:2721–2731
  9. Bruunsgaard H, Pedersen M, Pedersen BK. Aging and proinflammatory cytokines. Current Opinion in Hematology. 2001;8:131–136
  10. Cloez-Tayarani I, Petit-Bertron A-F, Venters HD, Cavaillon J-M. Differential effect of serotonin on cytokine production in lipopolysaccharide-stimulated human peripheral blood mononuclear cells: involvement of 5-hydroxytryptamine2A receptors. International Immunology. 2003;15:233–240
  11. Dantzer R, Bluthe RM, Gheusi G, Cremona S, Laye S, Parnet P, et al. Molecular basis of sickness behavior. Annals of the New York Academy of Sciences. 1998;29(856):132–138
  12. Di Giovanni G, Di Matteo V, Di Mascio M, Esposito E. Preferential modulation of mesolimbic vs. nigrostriatal dopaminergic function by serotonin (2C/2B) receptor agonists: a combined in vivo electrophysiological and microdialysis study. Synapse. 2000;35:53–61
  13. Finocchiaro LM, Arzt ES, Fernandez-Castelo S, Criscuolo M, Finkielman S, Nahmod VE. Serotonin and melatonin synthesis in peripheral blood mononuclear cells: stimulation by interferon-gamma as part of an immunomodulatory pathway. Journal of Interferon Research. 1988;8:705–716
  14. Grimaldi B, Fillion G. 5-HT-moduline controls serotonergic activity: implication in neuroimmune reciprocal regulation mechanisms. Progress in Neurobiology. 2000;60:1–12
  15. Hellstrand K, Hermodsson S. Serotonergic 5-HT1A receptors regulate a cell contact-mediated interaction between natural killer cells and monocytes. Scandinavian Journal of Immunology. 1993;37:7–18
  16. Hellstrand K, Czerkinsky C, Ricksten A, Jansson B, Asea A, Kylefjord H, et al. Role of serotonin in the regulation of interferon-gamma production by human natural killer cells. Journal of Interferon Research. 1993;13:33–38
  17. Kahn IA, Bhardwaj G, Malla N, Wattal C, Agarwal SC. Effect of serotonin on T lymphocyte proliferation in vitro in healthy individuals. International Archives of Allergy and Applied Immunology. 1986;81:378–380
  18. Kennett GA, Lightowler S, de Biasi V, Stevens NC, Wood MD, Tulloch IF, et al. Effect of chronic administration of selective 5-hydroxytryptamine and noradrenaline uptake inhibitors on a putative index of 5-HT2C/2B receptor function. Neuropharmacology. 1994;33:1581–1588
  19. Kubera M, Kenis G, Bosmans E, Scharpe S, Maes M. Effects of serotonin and serotonergic agonists and antagonists on the production of interferon-gamma and interleukin-10. Neuropsychopharmacology. 2000;23:89–98
  20. Kubera M, Kenis G, Bosmans E, Zieba A, Dudek D, Nowak G, et al. Plasma levels of interleukin-6, interleukin-10, and interleukin-1 receptor antagonist in depression: comparison between the acute state and after remission. Polish Journal of Pharmacology. 2000;52:237–241
  21. Kubera M, Lin A, Kenis G, Bosmans E, van Bockstaele D, Maes M. Anti-inflammatory effects of antidepressants through suppression of the interferon-gamma/interleukin-10 production ratio. Journal of Clinical Psychopharmacology. 2001;21:199–206
  22. Laberge S, Cruikshank WW, Beer DJ, Center DM. Secretion of IL-16 (lymphocyte chemoattractant factor) from serotonin-stimulated CD8+ T cells in vitro. Journal of Immunology. 1996;156:310–315
  23. Maes M. The immunoregulatory effects of antidepressants. Human Psychopharmacology. 2001;16:95–103
  24. Maes M, Meltzer HY. The serotonin hypothesis of major depression. In:  Bloom F,  Kupfer D editor. Psychopharmacology: The Fourth Generation of Progress. New York: Raven Press; 1995;p. 933–944
  25. Maes M, Meltzer HY, Bosmans E, Bergmans R, Vandoolaeghe E, Ranjan R, et al. Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. Journal of Affective Disorders. 1995;34:301–309
  26. Maes M, DeVos N, Wauters A, Demedts P, Maurits VW, Neels H, et al. Inflammatory markers in younger vs elderly normal volunteers and in patients with Alzheimer's disease. Journal of Psychiatric Research. 1999;33:397–405
  27. Maes M, Kenis G, Bosmans E. The negative immunoregulatory effects of serotonin (5-HT) moduline, an endogenous 5-HT1B receptor antagonist with anti-anxiety properties. Cytokine. 2002;19:308–311
  28. Marazziti D, Palego L, Dal Canto B, Rotondo A, Pasqualetti M, Giannaccini G, et al. Presence of serotonin1A (5-HT1A) receptor mRNA without binding of [3H]-8-OH-DPAT in peripheral blood mononuclear cells. Life Sciences. 1995;24:2197–2203
  29. Marazziti D, Ori M, Nardini M, Rossi A, Nardi I, Cassano GB. mRNA expression of serotonin receptors of type 2C and 5A in human resting lymphocytes. Neuropsychobiology. 2001;43:123–126
  30. Mikova O, Yakimova R, Bosmans E, Kenis G, Maes M. Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis. European Neuropsychopharmacology. 2001;11:203–208
  31. Mössner R, Lesch KP. Role of serotonin in the immune system and in neuroimmune interactions. Brain Behavior and Immunity. 1998;12:249–271
  32. Nieuwland R, Berckmans RJ, McGregor S, Boing AN, Romijn FPH, Westendorp RGJ, et al. Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. Blood. 2000;95:930–935
  33. Roszman TL, Jackson JC, Cross RJ, Titus MJ, Markesbery WR, Brooks WH. Neuroanatomic and neurotransmitter influences on immune function. Journal of Immunology. 1985;135:769s–772s
  34. Sluzewska A, Rybakowski JK, Sobieska M, Bosmans E, Pollet H, Wiktorowicz K. Increased levels of alpha-1-acid glycoprotein and interleukin-6 in refractory depression. Depression. 1996;39:149–155
  35. Young MRI, Matthews J. Serotonin regulation of T-cell subpopulations and of macrophage accessory function. Immunology. 1995;84:148–152
  36. Young MRI, Kut JL, Coogan MP, Wright MA, Young ME, Matthews J. Stimulation of splenic T-lymphocyte function by endogenous serotonin and by low-dose exogenous serotonin. Immunology. 1993;80:395–400

PII: S0165-1781(05)00048-X

doi: 10.1016/j.psychres.2004.01.014

Psychiatry Research
Volume 134, Issue 3 , Pages 251-258 , 30 April 2005

Article Tools

* Image Usage & Resolution